高级检索
当前位置: 首页 > 详情页

Structural Modulation of Gut Microbiota in Rats with Allergic Bronchial Asthma Treated with Recuperating Lung Decoction

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE ◇ CSCD-C

单位: [1]Beijing University of Chinese Medicine, Beijing 100029, China [2]Second Department of TCM Pulmonary Disease, The Key Institute of State Administration of Traditional Chinese Medicine (pneumonopathy chronic cough and dyspnea), Beijing Key Laboratory (NO. BZ0321), China-Japan Friendship Hospital, Beijing 100029, China [3]State Key Laboratory for Infectious Diseases Prevention and Control, and National Institute for Communicable Disease Control and Prevention, Beijing 102206, China, Chinese Center for Disease Control and Prevention. Collaborative Innovation Center Diagnosis and Treatment of Infectious Disease, Hangzhou 310003, Zhejiang, China [4]Institute of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing Key Laboratory of Emerging Infectious Diseases, Beijing 100015, China [5]Nephrology Department, Aviation General Hospital of China Medical University, Beijing 100012, China
出处:
ISSN:

关键词: Asthma Gut microbiota Recuperating lung decoction

摘要:
Objective To investigate whether recuperating lung decoction (RLD) can modulate the composition of gut microbiota in rats during asthma treatment. Methods Fifteen Sprague-Dawley rats were divided randomly and equally into control group, model group, dexamethasone (DEX) group, RLD medium-dose group, and RLD high-dose group. The asthma model was established in all groups, except for the control group. The rats in the DEX and RLD groups were treated orally with DEX and RLD, respectively. The rats in the control and model groups were treated orally with 0.9% saline. The intestinal bacterial communities were compared among groups using 16S rRNA gene amplification and 454 pyrosequencing. Results The microbial flora differed between the control and model groups, but the flora in the RLD groups was similar to that in the control group. No significant differences were observed between the RLD high-dose and medium-dose groups. RLD treatment resulted in an increase in the level beneficial bacteria in the gut, such as Lactobacillus and Bifidobacterium spp. Conclusion Oral administration of RLD increased the number of intestinal lactic acid-producing bacteria, such as Lactobacillus and Bifidobacterium, in asthma model rats.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2015]版:
大类 | 4 区 环境科学与生态学
小类 | 4 区 环境科学 4 区 公共卫生、环境卫生与职业卫生
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 环境科学 4 区 公共卫生、环境卫生与职业卫生
JCR分区:
出版当年[2014]版:
Q2 ENVIRONMENTAL SCIENCES Q2 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH
最新[2023]版:
Q2 ENVIRONMENTAL SCIENCES Q2 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH

影响因子: 最新[2023版] 最新五年平均[2021-2025] 出版当年[2014版] 出版当年五年平均[2010-2014] 出版前一年[2013版] 出版后一年[2015版]

第一作者:
第一作者单位: [1]Beijing University of Chinese Medicine, Beijing 100029, China
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:1320 今日访问量:0 总访问量:816 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)